IPR
Topic 127 Bilateral Regional Framework
Topic 127 — Bilateral and Regional IP Framework
Beyond multilateral WIPO and TRIPS framework, India's international IP commitments are shaped by bilateral and regional agreements. India has 100+ Bilateral Investment Treaties (BITs) — though many are now under termination/renegotiation. Major free trade agreements (FTAs) and regional frameworks: INDIA-EU FTA (negotiations active 2007-onwards; recent acceleration 2022-2024); INDIA-UK FTA (concluded 2025); INDIA-EFTA Trade and Economic Partnership Agreement (TEPA — signed 10 March 2024; entry into force 1 December 2025); INDIA-AUSTRALIA Comprehensive Economic Cooperation Agreement (CECA) (Interim Trade Agreement IECA effective 29 December 2022; full CECA negotiations); INDIA-UAE Comprehensive Economic Partnership Agreement (CEPA) (effective 1 May 2022); INDIA-MAURITIUS Comprehensive Economic Cooperation and Partnership Agreement (CECPA) (effective 1 April 2021). India's strategic position: WITHDREW from REGIONAL COMPREHENSIVE ECONOMIC PARTNERSHIP (RCEP) in November 2019 — primarily over IP TRIPS-Plus + agricultural concerns. CEPA with UAE includes IP provisions but balanced. EFTA TEPA includes commitments on patents, trademarks, designs, GIs, copyright. India-EU FTA negotiations focus on TRIPS-Plus issues. Bilateral Investment Treaties — India terminated old BITs in 2016-2019; new model BIT 2016 has narrower scope. The 2024 WIPO Treaty on Genetic Resources + Traditional Knowledge represents new multilateral progress. India's strategic approach: PRESERVE TRIPS flexibilities; OPPOSE TRIPS-Plus; STRENGTHEN South-South cooperation; PROMOTE Indian IP interests abroad. The Mediation Act 2023 + Arbitration and Conciliation (Amendment) Act 2024 provide frameworks for international IP disputes. This topic walks through India's bilateral and regional IP framework — major agreements, India's strategic position, and emerging considerations.
1. India's Strategic Framework
A. Multi-Layered International IP Strategy
✅ India's International IP Approach 1. WTO TRIPS · Foundational compliance. · TRIPS flexibilities preservation. · Section 3(d) anti-evergreening. · Section 84 compulsory licensing. 2. WIPO TREATIES · Selective membership. · Paris (1998), Berne (1928), PCT (1998), Madrid Protocol (2013), Hague Geneva Act (2014), Marrakesh (2014), Beijing (2020), Budapest (2001). · NOT Lisbon, WCT, WPPT. 3. BILATERAL TREATIES · India-EU FTA (negotiations). · India-UK FTA (2025). · India-EFTA TEPA (2024-2025). · India-UAE CEPA (2022). · India-Mauritius CECPA (2021). · India-Australia CECA/IECA (2022). 4. REGIONAL FRAMEWORKS · RCEP withdrawn 2019. · South Asian framework limited. · Strategic engagement. 5. POLICY POSITIONS · OPPOSE TRIPS-Plus provisions. · PRESERVE public health flexibilities. · STRENGTHEN South-South cooperation. · PROMOTE Indian IP interests. |
2. Bilateral Investment Treaties (BITs)
A. Indian BIT Framework
- 100+ BITs at peak (~2014).
- India terminated old BITs from 2016-2019.
- India's Model BIT 2016 — narrower scope.
- Balances investor protection with policy autonomy.
- Limited IP-specific provisions.
B. Model BIT 2016 Key Features
- "Investment" definition narrowed.
- Excludes purely financial assets.
- Local remedies exhaustion required.
- Limited scope of ISDS (Investor-State Dispute Settlement).
- Public policy carve-outs strong.
- IP — limited specific provisions.
3. Major Free Trade Agreements
A. India-UAE Comprehensive Economic Partnership Agreement (CEPA)
✅ India-UAE CEPA (Effective 1 May 2022) Foundational Framework: · Comprehensive Economic Partnership Agreement. · Effective: 1 May 2022. · Major goods + services + IP framework. IP Provisions: · Trademark cooperation. · Geographical indications mutual recognition. · Copyright cooperation. · Patent cooperation framework. · No TRIPS-Plus (preserved national flexibility). Bilateral Trade: · India's third-largest trading partner. · $80+ billion bilateral trade. · Significant Indian diaspora. · Banking + financial services cooperation. Strategic Significance: · Demonstrates India's balanced FTA approach. · Strong economic engagement without TRIPS-Plus. · Foundation for future FTAs. |
B. India-Mauritius CECPA
- Effective: 1 April 2021.
- Comprehensive Economic Cooperation and Partnership Agreement.
- Strategic for South-South cooperation.
- Includes IP provisions aligned with TRIPS.
- Tax framework integration.
C. India-Australia CECA / IECA
- Interim Trade Agreement (IECA) effective: 29 December 2022.
- Full Comprehensive Economic Cooperation Agreement (CECA) negotiations ongoing.
- Education + IP + investment provisions.
- Strategic Indo-Pacific economic engagement.
D. India-EFTA Trade and Economic Partnership Agreement (TEPA)
✅ India-EFTA TEPA (Signed 10 March 2024; Effective 1 December 2025) EFTA — European Free Trade Association: · Switzerland, Norway, Iceland, Liechtenstein. · Major financial services + R&D economies. Framework: · Signed: 10 March 2024. · Entry into Force: 1 December 2025. · $100 billion investment commitment from EFTA in 15 years. · 1 million jobs commitment. IP Provisions: · Commitments on patents, trademarks, designs, copyright. · Geographical indications mutual recognition. · No major TRIPS-Plus on patent term extension. · Pharmaceutical patents — balanced approach. · Anti-counterfeiting cooperation. Strategic Significance: · India's first major FTA with European economic partner. · Demonstrates IP balanced approach. · Foundation for India-EU FTA framework. · Strong investment commitment. |
E. India-UK FTA
- Negotiations 2022-2024.
- Concluded: 2025.
- IP provisions balanced.
- No TRIPS-Plus on pharmaceutical patents.
- Anti-counterfeiting cooperation.
- Significant Indian-UK IP trade.
F. India-EU FTA (Negotiations Active)
- Negotiations resumed 2022.
- Major issues: pharmaceutical patents, GIs, data protection.
- IP TRIPS-Plus debates.
- Pharmaceutical patent term extension contested.
- Continued discussions.
4. RCEP — India's Withdrawal
📖 Regional Comprehensive Economic Partnership (RCEP) — India Withdrew November 2019 Background — RCEP — Asia-Pacific regional trade agreement among China, Japan, Korea, ASEAN, Australia, New Zealand. Concluded 15 November 2020. India's Position — INDIA WITHDREW from negotiations in November 2019 — primarily over: · IP TRIPS-Plus concerns. · Pharmaceutical patent term extension. · Data exclusivity provisions. · Agricultural sector vulnerabilities. · Trade deficit concerns. Outcome — India did not sign final RCEP agreement. Significance — India's strategic clarity: · Refusal to compromise TRIPS flexibilities. · Public health considerations. · Strategic autonomy. · Foundation for future trade strategy. · Indian generic pharmaceutical industry preserved. |
5. TRIPS-Plus Provisions in FTAs
A. Common TRIPS-Plus Provisions
TRIPS-Plus Provision | Description | India Position |
|---|---|---|
Patent term extension | Beyond 20 years for regulatory delay. | OPPOSED. |
Data exclusivity | Pharmaceutical test data protection. | OPPOSED. |
Stricter compulsory licensing | Restrictions beyond TRIPS Article 31. | OPPOSED. |
Patent linkage | Linking marketing approval to patent status. | OPPOSED. |
Border measures expansion | Beyond TRIPS counterfeit/copyright. | CAUTIOUS. |
ISP liability | Stronger intermediary obligations. | CAUTIOUS. |
GI expansion | Beyond TRIPS Article 22. | CAUTIOUS. |
Strict three-step interpretation | Restrictive fair use. | CAUTIOUS. |
Investor-State Dispute Settlement | Direct investor lawsuits. | NARROWED 2016. |
B. India's Bargaining Position
- Strong public health considerations.
- Generic pharmaceutical industry protection.
- National flexibility preservation.
- TRIPS commitments + minimal additional obligations.
- Reciprocity considerations.
6. India's IP Strategic Cooperation
A. South-South Cooperation
- Technical assistance to LDCs.
- TRIPS waiver advocacy with developing countries.
- UN-level IP discussions.
- BRICS coordination.
- Indian IP best practices sharing.
B. WIPO Engagement
- Active in WIPO Standing Committees.
- IP Genetic Resources + Traditional Knowledge Treaty leadership (May 2024).
- Patent Law Treaty engagement.
- Madrid + Hague + PCT system promotion.
C. WTO Engagement
- TRIPS Council active participation.
- Doha Declaration follow-up.
- MC12 Decision (June 2022) on COVID vaccines.
- Continued vaccine access advocacy.
- Public health flexibility leadership.
7. Recent Developments (2022-2025)
Development | Year | Significance |
|---|---|---|
India-Mauritius CECPA effective | 1 April 2021 | South-South cooperation. |
India-UAE CEPA effective | 1 May 2022 | Major balanced FTA. |
India-Australia IECA effective | 29 December 2022 | Indo-Pacific engagement. |
MC12 Decision (COVID vaccines) | 17 June 2022 | TRIPS waiver advocacy success. |
Article 31bis post-2017 effectiveness | Ongoing | Multilateral compulsory licensing for export. |
India-EFTA TEPA signed | 10 March 2024 | First major Europe FTA. |
WIPO Treaty Genetic Resources | May 2024 | New multilateral framework. |
India-UK FTA concluded | 2025 | Major Anglo-Indian framework. |
India-EFTA TEPA effective | 1 December 2025 | Operational framework. |
India-EU FTA negotiations | Ongoing | TRIPS-Plus debates. |
8. Strategic Considerations
✅ For Indian businesses — eight points For UAE market, leverage CEPA framework. For European partners, prepare for EFTA TEPA framework. For Indo-Pacific, leverage Australia IECA + future CECA. For UK, leverage 2025 FTA. For RCEP-style multilateral, monitor developments. For South-South cooperation, leverage Indian IP framework. For TRIPS flexibilities, document Indian framework leverage. For investment protection, navigate Model BIT 2016. |
✅ For India's strategic IP positioning — six points Continue OPPOSING TRIPS-Plus provisions. Continue PRESERVING public health flexibilities. Continue STRENGTHENING South-South cooperation. Continue WIPO + WTO active engagement. Continue balanced FTA negotiations. Continue domestic IP framework refinement. |
9. Memory Aid — Quick Recall
✅ Quick Recall — Bilateral and Regional Framework India-Mauritius CECPA effective 1 April 2021. India-UAE CEPA effective 1 May 2022. India-Australia IECA effective 29 December 2022. India-EFTA TEPA signed 10 March 2024; effective 1 December 2025. India-UK FTA concluded 2025. India-EU FTA negotiations ongoing. India WITHDREW from RCEP November 2019. India's Model BIT 2016 — narrower scope. India POSITION: oppose TRIPS-Plus; preserve flexibilities; South-South cooperation. TRIPS-Plus opposed: patent term extension, data exclusivity, stricter CL, patent linkage. India-UAE: $80+ billion trade. India-EFTA: $100 billion investment + 1 million jobs commitment. WIPO Treaty May 2024 — Genetic Resources + Traditional Knowledge. MC12 Decision June 2022 — COVID vaccines. |
🎯 EXAM POINTERS — TOPIC 127
|